Overall impact
B (79)

Commentary

Motus GI is a strong overall performer. With a 'B' rating of 78.9 for overall impact (93rd percentile compared to all companies), Motus GI ranks 5th out of 96 industry peers, behind Ellume, Imprivata, Certara and 1 other, and ahead of Suvoda, Gainwell Technologies, Maximus and 88 others. On top material causes for Motus GI's industry (Healthcare Software & Services), Motus GI performs well in Free, Secure Flow of Information (81.5 score), Child and Maternal Health (85.2), Reduced Use of tobacco (85.4) and 7 other causes where it received an 'A' score. Motus GI did not receive a 'D' or 'F' rating on any cause.
Impact
Cause MOTS
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
15
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Software & IT Services
Headquarters
Fl, United States
Share classes
MOTS
Description
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops the Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Material causes
Ethos considers the following causes material for Motus GI, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.